Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Phosphate Assessment in Chronic Kidney Disease Patients Study

University of Texas Southwestern Medical Center · NCT07368946

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
60
US sites recruiting
1
Study start
May 9, 2025
Record last updated
January 28, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The proposed pilot feeding study aims to explore novel pathways in phosphate metabolism and identify new biomarkers, as well as to develop a compound index for assessing phosphate overload with high validity and reliability.

Investigators will address the following specific aims: 1). To explore novel pathways of phosphate metabolism and assess the influence of CKD status on these metabolic pathways. 2). To identify novel biomarkers for phosphate overload that reflect changes in dietary phosphorus intake. 3). To develop a compound phosphate overload index that measures dietary phosphorus intake with high validity and reliability.

This study will provide novel insights into phosphate metabolism and the assessment of phosphate overload in CKD patients. This investigation aims to provide preliminary data to further studies for the development of reliable biomarkers in CKD patients, which could contribute significantly to early interventions and improve health outcomes.

Being studied: Dietary Phosphorus Intake

Conditions: Chronic Kidney Disease (Stage 3-4); Chronic Kidney Disease Mineral and Bone Disorder

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Men or women aged 18 years or older, of any race/ethnicity
  • Women must either be post-menopausal or have no monthly menstrual cycle
  • Estimated total daily energy expenditure (TDEE) of 1700 - 2700 calories
  • eGFR >15 ml/min/1.73m2 - \< 60 ml/min/1.73m2 for the CKD group (CKD Stage 3 or Stage 4)
  • eGFR ≥ 60 ml/min/1.73m2 and negative urine protein on dipstick test for the non-CKD group
  • English speaking

Exclusion Criteria

  • Pregnant, currently breastfeeding, or \<3 months postpartum
  • Current dialysis or kidney transplant patient
  • Current use of insulin or chemotherapy drugs
  • Smokes cigarettes or uses e-cigarettes (vapes)
  • Uses nicotine products or other recreational drugs
  • Medical history of stroke or myocardial infarction (MI)
  • Medical history of conditions that can affect phosphate metabolism (i.e., uncontrolled thyroid disorder, parathyroid disorder, or gastrointestinal malabsorption disorders [Crohn's, ulcerative colitis, and celiac disease], cirrhosis)
  • Current use of certain medications that directly alter phosphate levels (i.e., phosphate binders; phosphate supplements, irregular use of iron)
  • Regular use of laxatives
  • Hypo- or hyperphosphatemia (serum phosphate \< 2.5 or > 4.6 mg/dl)
  • Hypo- or hypercalcemia (serum calcium \< 8.4 or > 10.7 mg/dl)
  • Severe anemia (hemoglobin \< 8 g/dl for women and \< 9 g/dl for men)
  • Severe hyperglycemia (serum blood glucose > 300 mg/dl)
  • Body weight less than \<110 lbs (due to risk for phlebotomy-induced anemia)
  • Received a blood transfusion in the last four months
  • Extreme hypertension as demonstrated by a blood pressure > 180/120 as the average of 3 blood pressures taken during the screening/baseline, or extremely low blood pressure \< 80/50
  • Unwilling or unable to eat study meals
  • Lack of access to a functional refrigerator or freezer
  • Lack of access to a microwave or conventional oven
  • On low potassium diet
  • On low phosphate diet
  • Specific dietary restrictions (i.e. vegetarian, vegan, ketogenic, etc.)
  • Food allergies including but not limited to milk, egg, soy, nuts, shellfish, and wheat or gluten
  • Allergic to sodium phosphate
  • Unable or unwilling to complete urinary sample collection or food diaries
  • Unable or unwilling to provide informed consent
  • Unable to read or speak English
  • Participant in other conflict clinical trial
  • Unable to complete the study measurements
  • Unsafe to participate in this study per investigator's judgement

Recruiting US locations

  • University of Texas Southwestern Medical Center

    Dallas, TX 75390

    Site contact: Alexandra Hartman · 2146458294 · pack.utsw@utsouthwestern.edu

Study contacts (from the official record)

  • Alexandra Hartman · 214-645-8294 · pack.utsw@utsouthwestern.edu
  • Paola Lanza, MD · 469-852-9550 · paola.lanza@utsouthwestern.edu
All nutrition & metabolism studies in Texas →
Phosphate Assessment in Chronic Kidney Disease Patients Study (NCT07368946) | Bored Studies